CrushSCI.com
97.3平均天数
83中位天数
30最短天数
201最长天数
1342025发文量

Paper Review Records

全部论文审稿周期

15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

186 天

Construction of a lung adenocarcinoma overall survival prognostic model based on monocyte-derived macrophage signature genes and exploration of immune crosstalk plus Pan-Cancer prognostic disparities

作者
Yong Zhang; Lanbo Liu; Jie Ma; Shihui Xia展开收起
作者单位
Department of Cardiothoracic Surgery, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, No. 136, Jingzhou Street, Xiangcheng District, 441106 Xiangyang, Hubei, China展开收起
PDF源文件 DOI 网页
30 天

A novel CD123xVδ2 bispecific T cell engager induces potent and tumor selective Vγ9Vδ2-T cell activity against CD123 expressing acute myeloid leukemia and myelodysplastic syndrome

作者
Jurjen M. Ruben; Charlotte M. Mousset; Dorien van de Berg; Kim Hofman; Milon de Jong; Patricia Brouwer; Sanne Graeve; Victoria Iglesias-Guimarais; Pauline M. van Helden; Anton E.P. Adang; Rob C. Roovers; Hans J. van der Vliet展开收起
作者单位
Department of Medical Oncology, Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Amsterdam, 1081 HV, the Netherlands; LAVA Therapeutics N.V, Utrecht, the Netherlands; Engager BIO B.V, Amstelveen, the Netherlands展开收起
PDF源文件 DOI 网页
54 天

Genetic and clinical evidence supports HLA-DR+ CD8+ T cells as a favorable immune biomarker in acute myeloid leukemia

作者
Gang Chen; Jing Xu; Xiaoyu He; Yixin Yan; Linhui Hu; Zhenjiang Li展开收起
作者单位
Department of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China展开收起
PDF源文件 DOI 网页
84 天

Development of bi-functional hybrid IgGA antibodies for enhancing cancer immunotherapy

作者
Xiuyun Li; Vladislav Rybchenko; Naida Mamaeva; Jingyan Wang; Dmitry Dolgikh; Baohang Lin; Victoria Argentova展开收起
作者单位
Faculty of Biology, Shenzhen MSU-BIT University, Shenzhen 518172, China; Department of Thyroid, Breast and Vascular Surgery, Longgang Central Hospital of Shenzhen, Shenzhen 518000, China; Faculty of Biology, Lomonosov Moscow State University, Moscow 119991, Russia; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry (IBKh), Russian Academy of Sciences, Moscow 117997, Russia展开收起
PDF源文件 DOI 网页
90 天

The relationship between autoantibody and complement levels in the sera of patients with systemic lupus erythematosus

作者
David S. Pisetsky; Yuankang Zhao; Matthew Engelhard; Amanda Eudy; Philip Tedeschi; Tyler O'Malley; Roberta Vezza Alexander; Megan Clowse; Lisa Criscione-Schreiber; Jayanth Doss; Mithu Maheswaranathan; Rebecca Sadun; Kai Sun; Nathaniel Harris; Jennifer Rogers展开收起
作者单位
Duke University School of Medicine, Department of Medicine, Durham, NC, USA; Durham VA Medical Center, Durham, NC, USA; Duke University School of Medicine, Department of Biostatistics & Bioinformatics, Durham, NC, USA; Immunovant, Inc., New York, NY, USA; Exagen, Inc., Vista, CA, USA展开收起
PDF源文件 DOI 网页
127 天

TIM-3 as a therapeutic target in anaplastic thyroid carcinoma: Preclinical and transcriptomic evidence supporting a new immunotherapy avenue

作者
Monikongkona Boruah; Riyaz Ahmad Mir; Sameer Rastogi; Kapil Sikka; Shipra Agarwal展开收起
作者单位
Department of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, India; Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), New Delhi, India; Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India; Department of Otorhinolaryngology and Head and Neck Surgery, All India Institute of Medical Sciences (AIIMS), New Delhi, India展开收起
PDF源文件 DOI 网页

FAQ

CLINICAL IMMUNOLOGY审稿要多久?

截至2026-11-14,CrushSCI 收录了 CLINICAL IMMUNOLOGY 的 15 篇完整审稿记录。最快一篇从收稿到录用用了 30 天(A novel CD123xVδ2 bispecific T cell engager induces potent and tumor selective Vγ9Vδ2-T cell activity against CD123 expressing acute myeloid leukemia and myelodysplastic syndrome,2026-09-22 收稿,2026-10-22 录用),最慢一篇用了 201 天;平均 97.3 天,中位数 83 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。